A Virginia Tech research program offering a giant knotweed extract foliar treatment that achieves 100% control of fire blight shoot blight severity and canker incidence on pear. The organic-approved solution matches oxytetracycline spray performance and supports reduced antibiotic use in fruit production.
This solution from Virginia Tech addresses fire blight, a devastating bacterial disease caused by Erwinia amylovora that threatens pear and apple orchards worldwide. The research team has demonstrated that foliar applications of giant knotweed extract, a product already approved for organic fruit production, can deliver complete control of shoot blight severity and prevent canker development on Bartlett pear, the most susceptible host of this pathogen. The treatment performed comparably to oxytetracycline foliar sprays, offering growers an effective alternative that avoids the regulatory and resistance concerns associated with antibiotic use in tree fruit production.
The treatment has been validated in inoculated field trials on Bartlett pear with confirmed 100% efficacy for the giant knotweed foliar protocol. The research team is seeking funding to repeat the experiment in one additional growing season, increasing replicates from 3 to 4 pear trees per treatment across all five treatments plus an untreated control. The follow-up study will measure the same disease parameters and apply LSD and/or Tukey's test for statistical analysis. Funding is requested for a technician to serve as key personnel for conducting the experiment. Upon confirmation of consistent results, the protocol will be ready for adoption by both organic and conventional pear growers.
Virginia Polytechnic Institute and State University (Virginia Tech) is a comprehensive public land‑grant research university with broad graduate and professional programs and a strong industry orientation. An adjacent research and technology park links companies with faculty, shared labs, and prototyping resources, while facilities in the National Capital Region create a direct connection to federal partners and supply‑chain collaborators. Integration with a regional health system supports clinical research and translational pathways, and the statewide extension network enables field deployment and validation with industry and communities. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, and the Department of Defense. A dedicated technology transfer office provides IP management, licensing, startup formation, and industry contracting support.